These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 29948570)
1. Screening Women Aged 50-59 for CRC Using Fecal Occult Blood Test Produces Outcomes Similar to Men Undergoing Screening Colonoscopy. Mooers HM; Holub JL; Lieberman DA Dig Dis Sci; 2018 Oct; 63(10):2780-2785. PubMed ID: 29948570 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. Lieberman DA; Holub JL; Moravec MD; Eisen GM; Peters D; Morris CD JAMA; 2008 Sep; 300(12):1417-22. PubMed ID: 18812532 [TBL] [Abstract][Full Text] [Related]
3. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514 [TBL] [Abstract][Full Text] [Related]
4. Race, ethnicity, and sex affect risk for polyps >9 mm in average-risk individuals. Lieberman DA; Williams JL; Holub JL; Morris CD; Logan JR; Eisen GM; Carney P Gastroenterology; 2014 Aug; 147(2):351-8; quiz e14–5. PubMed ID: 24786894 [TBL] [Abstract][Full Text] [Related]
5. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011). Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192 [TBL] [Abstract][Full Text] [Related]
6. Contribution of the OC Sensor Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183 [TBL] [Abstract][Full Text] [Related]
7. Comparison of colorectal cancer screening and diagnoses in HIV-positive and HIV-negative veterans. Guest JL; Rentsch CT; Rimland D AIDS Care; 2014; 26(12):1490-3. PubMed ID: 25008192 [TBL] [Abstract][Full Text] [Related]
8. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study. Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978 [TBL] [Abstract][Full Text] [Related]
9. Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood test. Ferlitsch M; Heinze G; Salzl P; Britto-Arias M; Waldmann E; Reinhart K; Bannert C; Fasching E; Knoflach P; Weiss W; Trauner M; Ferlitsch A Med Oncol; 2014 Sep; 31(9):151. PubMed ID: 25115743 [TBL] [Abstract][Full Text] [Related]
10. Performance of multitarget stool DNA testing in African American patients. Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L Cancer; 2018 Oct; 124(19):3876-3880. PubMed ID: 30193399 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia. Tsoi KK; Ng SS; Leung MC; Sung JJ Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075 [TBL] [Abstract][Full Text] [Related]
12. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Inadomi JM; Vijan S; Janz NK; Fagerlin A; Thomas JP; Lin YV; Muñoz R; Lau C; Somsouk M; El-Nachef N; Hayward RA Arch Intern Med; 2012 Apr; 172(7):575-82. PubMed ID: 22493463 [TBL] [Abstract][Full Text] [Related]
13. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial. You JJ; Liu Y; Kirby J; Vora P; Moayyedi P Trials; 2015 Jul; 16():296. PubMed ID: 26156248 [TBL] [Abstract][Full Text] [Related]
14. Breast, cervical, and colorectal carcinoma screening in a demographically defined region of the southern U.S. Coughlin SS; Thompson TD; Seeff L; Richards T; Stallings F Cancer; 2002 Nov; 95(10):2211-22. PubMed ID: 12412176 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M; J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of screening for colorectal cancer in the general population. Frazier AL; Colditz GA; Fuchs CS; Kuntz KM JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892 [TBL] [Abstract][Full Text] [Related]
17. The first 3 years of national bowel cancer screening at a single UK tertiary centre. Gupta S; Saunders BP; Fraser C; Kennedy RH; Ignjatovic A; Sala S; Marshall S; Suzuki N; Vance M; Thomas-Gibson S Colorectal Dis; 2012 Feb; 14(2):166-73. PubMed ID: 21689280 [TBL] [Abstract][Full Text] [Related]
18. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals. Álvarez C; Andreu M; Castells A; Quintero E; Bujanda L; Cubiella J; Salas D; Lanas Á; Carballo F; Morillas JD; Hernández C; Jover R; Sarasqueta C; Enriquéz-Navascués JM; Hernández V; Estévez P; Macenlle R; Sala T; Balaguer F; Pellisé M; Moreira L; Gil I; Peris A; González-Rubio F; Ferrández A; Poves C; Ponce M; Grau J; Serradesanferm A; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; Santander C; Díaz Tasende J; Herreros A; Cacho G; Barranco LE; Bessa X; Gastrointest Endosc; 2013 Aug; 78(2):333-341.e1. PubMed ID: 23623039 [TBL] [Abstract][Full Text] [Related]
19. Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance. Lieberman D; Sullivan BA; Hauser ER; Qin X; Musselwhite LW; O'Leary MC; Redding TS; Madison AN; Bullard AJ; Thomas R; Sims KJ; Williams CD; Hyslop T; Weiss D; Gupta S; Gellad ZF; Robertson DJ; Provenzale D Gastroenterology; 2020 Mar; 158(4):862-874.e8. PubMed ID: 31376388 [TBL] [Abstract][Full Text] [Related]
20. Diminutive Polyps With Advanced Histologic Features Do Not Increase Risk for Metachronous Advanced Colon Neoplasia. Vleugels JLA; Hassan C; Senore C; Cassoni P; Baron JA; Rex DK; Ponugoti PL; Pellise M; Parejo S; Bessa X; Arnau-Collell C; Kaminski MF; Bugajski M; Wieszczy P; Kuipers EJ; Melson J; Ma KH; Holman R; Dekker E; Pohl H Gastroenterology; 2019 Feb; 156(3):623-634.e3. PubMed ID: 30395813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]